The present invention is directed to compounds and pharmaceutical
compositions comprising the compounds which are inhibitors of the enzyme
gamma secretase and which are useful in the treatment or prevention of
diseases in which the beta-amyloid peptide is involved, such as
Alzheimer's disease.
De onderhavige uitvinding wordt geleid aan samenstellingen en farmaceutische samenstellingen bestaand uit de samenstellingen die inhibitors van enzymgamma secretase zijn en die in de behandeling of de preventie van ziekten nuttig zijn waarbij bèta-amyloidpeptide betrokken is, zoals de ziekte van Alzheimer.
